The validation fund supports innovative projects of high translational potential at the Berlin Institute of Health, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC).
BIH, Charité and MDC researchers and clinicians from all areas, including pharmaceuticals, diagnostics, medical devices and digital health, can apply for funding to support their projects. Requirements are:

  • Intent to commercialize the invention, e.g., via licensing or founding a spin-off
  • Close cooperation with the team of Berlin Health Innovations.

Project support including mentoring and coaching is conducted in close collaboration with SPARK-BIH, which is part of Berlin Health Innovations.